首页> 外文期刊>Scientific reports. >Improving survival of acute-on-chronic liver failure patients complicated with invasive pulmonary aspergillosis
【24h】

Improving survival of acute-on-chronic liver failure patients complicated with invasive pulmonary aspergillosis

机译:改善慢性慢性肝功能衰竭并发侵袭性肺曲霉病的患者的生存

获取原文
       

摘要

The mortality of acute-on-chronic liver failure (ACLF) patients complicated with invasive pulmonary aspergillosis (IPA) was extremely high. We aimed to explore prognostic value of the Chronic Liver Failure-Sequential Organ Failure Assessment (CLIF-SOFA) lung score and to establish an optimal voriconazole regimen for ACLF patients complicated with IPA. We retrospectively screened hospitalized ACLF patients in our hospital from July 2011 to April 2016, from which 20 probable IPA cases were diagnosed. Along with onsets of IPA, deteriorated diseases severity, especially lung conditions were found in those 20 ACLF patients. It was found that IPA patients with CLIF-SOFA lung score 1 (11/13 vs 0/7, p 1 was able to identify ACLF patients complicated with IPA encountering much higher 28-day mortality. An optimal voriconazole regimen was safe and effective in our ACLF patients complicated with IPA.
机译:慢性肝功能衰竭(ACLF)并发侵袭性肺曲霉病(IPA)的死亡率极高。我们旨在探讨慢性肝功能衰竭-序贯器官功能衰竭评估(CLIF-SOFA)肺评分的预后价值,并为ACLF并发IPA的患者建立最佳伏立康唑治疗方案。我们对2011年7月至2016年4月在我院住院的ACLF患者进行了回顾性筛查,从中诊断出20例可能的IPA病例。随着IPA的发作,在这20名ACLF患者中发现疾病的严重程度恶化,尤其是肺部疾病。研究发现,CLIF-SOFA肺部评分为1(11/13 vs 0/7,p 1)的IPA患者能够鉴别出ACLF并发IPA且28天死亡率更高的患者。最佳伏立康唑治疗方案安全有效我们的ACLF患者并发IPA。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号